Innovation1 Biotech Inc. Stock Analysis IVBT
Innovation1 Biotech, Inc. is a clinical-stage drug discovery company, which focuses on developing modified Schedule 1 molecules of botanical origin for therapeutic use. The company is headquartered in Rockaway, New Jersey and currently employs 0 full-time employees. The company went IPO on 2017-02-06. The firm has no operations and is evaluating a number of strategic alternatives including, but not limited to, seeking to acquire a new business in the United States, including potentially by means of a reverse merger with an operating entity. The firm has no sources of revenue.
Read More Innovation1 Biotech Inc (IVBT) Chart
Key Statistics of Innovation1 Biotech Inc (IVBT)
Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.
Today's Range
Today's Open
$0.00Volume
4.00P/E Ratio (TTM)
-52 Week Range
Market Cap
4494.00Avg. Volume
4.00Dividend Yield
-Financial Metrics & Statements of Innovation1 Biotech Inc (IVBT)
FAQ's for Innovation1 Biotech Inc (IVBT)
- According to Musaffa’s Shariah screening methodology, Innovation1 Biotech Inc (IVBT) is currently classified as NOT COVERED as of May 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.